NASDAQ

NewAmsterdam Pharma Company N.V. - Ordinary Shares (NAMS)

♥ 542 Thanks from members

Live price chart, market sentiment, and community perspectives for NewAmsterdam Pharma Company N.V. (NASDAQ: NAMS).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: Health CareIndustry: BiotechnologyFounder: Esperion Therapeutics / The Medicines Company alumniLeadership: Michael Davidson (CEO)Leadership: David DeanHolder: FMR LLCHolder: RA Capital ManagementHolder: Perceptive AdvisorsBempedoic Acid pipelineObicetrapib#NAMS#NewAmsterdam Pharma#Cardiometabolic#NASDAQ NAMS#Biotech